Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
4 clinical trials · Condition
◉ Watch Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy (NCT06679946) | Alnylam Pharmaceuticals | 2024-12-03 |
| MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM) (NCT06128629) | Intellia Therapeutics | 2023-12-13 |
| HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy (NCT04153149) | Alnylam Pharmaceuticals | 2019-11-26 |
| APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy) (NCT03997383) | Alnylam Pharmaceuticals | 2019-09-04 |
Track Transthyretin Amyloidosis (ATTR) With Cardiomyopathy automatically
Every clearance here is in the API, with alerts when new ones post.